482 related articles for article (PubMed ID: 26984066)
1. Assessed value of high-sensitivity cardiac troponin T for cardiovascular disease among CKD patients.
Sun L; Tan X; Cao X; Zou J
Ren Fail; 2016 Jun; 38(5):728-37. PubMed ID: 26984066
[TBL] [Abstract][Full Text] [Related]
2. High-sensitive cardiac troponin T: a biomarker of left-ventricular diastolic dysfunction in hemodialysis patients.
Sun L; Ji Y; Wang Y; Ding M; Xie X; Zhu D; Chen F; Zhang N; Wang X
J Nephrol; 2018 Dec; 31(6):967-973. PubMed ID: 30350298
[TBL] [Abstract][Full Text] [Related]
3. Early markers of cardiovascular risk in chronic kidney disease.
Lai S; Dimko M; Galani A; Coppola B; Innico G; Frassetti N; Mazzei ED; Mariotti A
Ren Fail; 2015 Mar; 37(2):254-61. PubMed ID: 25394527
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic potential of serum biomarkers for left ventricular abnormalities in chronic peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Chan IH; Lui SF; Zhang Y; Sanderson JE
Nephrol Dial Transplant; 2009 Jun; 24(6):1962-9. PubMed ID: 19237403
[TBL] [Abstract][Full Text] [Related]
5. Association of cardiac troponin T with left ventricular structure and function in CKD.
Mishra RK; Li Y; DeFilippi C; Fischer MJ; Yang W; Keane M; Chen J; He J; Kallem R; Horwitz EJ; Rafey M; Raj DS; Go AS; Shlipak MG;
Am J Kidney Dis; 2013 May; 61(5):701-9. PubMed ID: 23291148
[TBL] [Abstract][Full Text] [Related]
6. Superior predictive value for NTproBNP compared with high sensitivity cTnT in dialysis patients: a pilot prospective observational study.
Voroneanu L; Siriopol D; Nistor I; Apetrii M; Hogas S; Onofriescu M; Covic A
Kidney Blood Press Res; 2014; 39(6):636-47. PubMed ID: 25571877
[TBL] [Abstract][Full Text] [Related]
7. Serum Cardiac Troponin-I is Superior to Troponin-T as a Marker for Left Ventricular Dysfunction in Clinically Stable Patients with End-Stage Renal Disease.
Buiten MS; de Bie MK; Rotmans JI; Dekker FW; van Buren M; Rabelink TJ; Cobbaert CM; Schalij MJ; van der Laarse A; Jukema JW
PLoS One; 2015; 10(8):e0134245. PubMed ID: 26237313
[TBL] [Abstract][Full Text] [Related]
8. Prediction of outcome by highly sensitive troponin T in outpatients with chronic systolic left ventricular heart failure.
Egstrup M; Schou M; Tuxen CD; Kistorp CN; Hildebrandt PR; Gustafsson F; Faber J; Goetze JP; Gustafsson I
Am J Cardiol; 2012 Aug; 110(4):552-7. PubMed ID: 22579083
[TBL] [Abstract][Full Text] [Related]
9. Improving Prediction of Postoperative Myocardial Infarction With High-Sensitivity Cardiac Troponin T and NT-proBNP.
Kopec M; Duma A; Helwani MA; Brown J; Brown F; Gage BF; Gibson DW; Miller JP; Novak E; Jaffe AS; Apple FS; Scott MG; Nagele P
Anesth Analg; 2017 Feb; 124(2):398-405. PubMed ID: 28002165
[TBL] [Abstract][Full Text] [Related]
10. High-sensitive troponin T in chronic heart failure correlates with severity of symptoms, left ventricular dysfunction and prognosis independently from N-terminal pro-b-type natriuretic peptide.
Jungbauer CG; Riedlinger J; Buchner S; Birner C; Resch M; Lubnow M; Debl K; Buesing M; Huedig H; Riegger G; Luchner A
Clin Chem Lab Med; 2011 Nov; 49(11):1899-906. PubMed ID: 21892905
[TBL] [Abstract][Full Text] [Related]
11. Cardiac biomarkers in pediatric CKD-a prospective follow-up study.
Lindblad YT; Vavilis G; Chromek M; Quershi AR; Löwbeer C; Bárány P
Pediatr Nephrol; 2022 Dec; 37(12):3165-3175. PubMed ID: 35294668
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor 23, high-sensitivity cardiac troponin, and left ventricular hypertrophy in CKD.
Smith K; deFilippi C; Isakova T; Gutiérrez OM; Laliberte K; Seliger S; Kelley W; Duh SH; Hise M; Christenson R; Wolf M; Januzzi J
Am J Kidney Dis; 2013 Jan; 61(1):67-73. PubMed ID: 22883134
[TBL] [Abstract][Full Text] [Related]
13. Cardiac biomarkers in systemic sclerosis: contribution of high-sensitivity cardiac troponin in addition to N-terminal pro-brain natriuretic peptide.
Avouac J; Meune C; Chenevier-Gobeaux C; Borderie D; Lefevre G; Kahan A; Allanore Y
Arthritis Care Res (Hoboken); 2015 Jul; 67(7):1022-30. PubMed ID: 25604469
[TBL] [Abstract][Full Text] [Related]
14. Association of high-sensitivity cardiac troponin T and natriuretic peptide with incident ESRD: the Atherosclerosis Risk in Communities (ARIC) study.
Kim Y; Matsushita K; Sang Y; Grams ME; Skali H; Shah AM; Hoogeveen RC; Solomon SD; Ballantyne CM; Coresh J
Am J Kidney Dis; 2015 Apr; 65(4):550-8. PubMed ID: 25446023
[TBL] [Abstract][Full Text] [Related]
15. High-sensitivity cardiac troponin T for detection of subtle abnormalities of cardiac phenotype in a general population of elderly individuals.
Masson S; Latini R; Mureddu GF; Agabiti N; Miceli M; Cesaroni G; Forastiere F; Wienhues-Thelen UH; Block D; Zaugg C; Vago T; Boccanelli A;
J Intern Med; 2013 Mar; 273(3):306-17. PubMed ID: 23216903
[TBL] [Abstract][Full Text] [Related]
16. Inflammation and disease activity are associated with high circulating cardiac markers in rheumatoid arthritis independently of traditional cardiovascular risk factors.
Avouac J; Meune C; Chenevier-Gobeaux C; Dieudé P; Borderie D; Lefevre G; Kahan A; Allanore Y
J Rheumatol; 2014 Feb; 41(2):248-55. PubMed ID: 24334650
[TBL] [Abstract][Full Text] [Related]
17. Association between high-sensitivity cardiac troponin T and future cardiovascular incidence in a general Japanese population: results from the Tohoku medical megabank project.
Takahashi Y; Satoh M; Ohmomo H; Tanaka F; Osaki T; Tanno K; Nasu T; Sakata K; Morino Y; Sobue K; Sasaki M
Biomarkers; 2019 Sep; 24(6):566-573. PubMed ID: 30978115
[No Abstract] [Full Text] [Related]
18. Associations of High-Sensitivity Cardiac Troponin and Natriuretic Peptide With Subsequent Risk of Infection in Persons Without Cardiovascular Disease: The Atherosclerosis Risk in Communities Study.
Ishigami J; Hoogeveen RC; Ballantyne CM; Folsom AR; Coresh J; Selvin E; Matsushita K
Am J Epidemiol; 2019 Dec; 188(12):2146-2155. PubMed ID: 31063194
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with baseline and serial changes in circulating NT-proBNP and high-sensitivity cardiac troponin T in a population-based cohort (Dallas Heart Study).
Puleo CW; Ayers CR; Garg S; Neeland IJ; Lewis AA; Pandey A; Drazner MH; de Lemos JA
Biomark Med; 2021 Nov; 15(16):1487-1498. PubMed ID: 34663078
[No Abstract] [Full Text] [Related]
20. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]